Department of Radiotherapy, Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom.
Radiology Department, Aintree University Hospital NHS Foundation Trust, United Kingdom.
Radiother Oncol. 2019 Mar;132:121-126. doi: 10.1016/j.radonc.2018.12.009. Epub 2018 Dec 31.
Cone beam CT (CBCT) is used to improve accuracy of radical radiotherapy by adjusting treatment to the observed imaging changes. To ensure appropriate adjustment, image interpretation should precede any changes to treatment delivery. This study provides the methodology for image interpretation and the frequency and evolution of the changes in patients undergoing radical radiotherapy for localised and locally advanced non-small cell lung cancer (NSCLC).
From December 2012 to December 2014, 250 patients with localised and locally advanced NSCLC had 2462 chest CBCT scans during the course of fractionated radical radiotherapy (RT) (3-5 daily CBCTs in the first week followed by at least weekly imaging, mean 9.5 per patient, range 1-21). All CBCT images were reviewed describing changes and their evolution using diagnostic imaging definitions and validated by an independent chest radiologist.
During radical RT for NSCLC 328 imaging changes were identified on CBCT in 180 (72%) patients; 104 (32%) had reduction and 41 (13%) increase in tumour size; 48 (15%) had changes in consolidations contiguous to the primary lesion, 26 (8%) non-contiguous consolidations, 43 (13%) changes in tumour cavitation, 36 (11%) pleural effusion and 30 (9%) changes in atelectasis. In 105 patients imaging changes were noted in continuity with the treated tumour of which only 41 (39%) represented tumour enlargement; others included new or enlarging adjacent consolidation (34%), and new or enlarging atelectasis (19%). The changes evolved during treatment.
Imaging changes on CBCT include real and apparent changes in tumour size and parenchymal changes which evolve during treatment. Correct image interpretation, particularly when occurring adjacent to the tumour, is essential prior to adjustment to treatment delivery.
锥形束 CT(CBCT)用于通过调整治疗方案以适应观察到的影像学变化,从而提高根治性放疗的准确性。为了确保进行适当的调整,应在更改治疗方案之前对图像进行解释。本研究提供了对图像进行解释的方法,以及在局部和局部晚期非小细胞肺癌(NSCLC)患者接受根治性放疗期间,肿瘤大小和实质变化的变化频率和演变情况。
从 2012 年 12 月至 2014 年 12 月,250 例局部和局部晚期 NSCLC 患者在分次根治性放疗(RT)过程中进行了 2462 次胸部 CBCT 扫描(第 1 周每天进行 3-5 次 CBCT,然后至少每周进行一次成像,每位患者平均 9.5 次,范围为 1-21 次)。所有 CBCT 图像均进行了评估,使用诊断影像学定义描述了变化及其演变,并由独立的胸部放射科医师进行了验证。
在 NSCLC 的根治性 RT 期间,180 例(72%)患者的 CBCT 上发现了 328 种影像学变化;其中 104 例(32%)肿瘤体积缩小,41 例(13%)肿瘤体积增大;48 例(15%)与原发性病变相邻的实变有变化,26 例(8%)非相邻实变,43 例(13%)肿瘤空洞有变化,36 例(11%)胸腔积液,30 例(9%)肺不张有变化。在 105 例与治疗肿瘤连续的患者中发现了影像学变化,其中只有 41 例(39%)代表肿瘤增大;其他包括新的或增大的相邻实变(34%)和新的或增大的肺不张(19%)。这些变化在治疗过程中发生了演变。
CBCT 上的影像学变化包括肿瘤大小和实质变化的真实和表观变化,这些变化在治疗过程中会不断演变。在调整治疗方案之前,正确的图像解释,特别是当发生在肿瘤附近时,至关重要。